The protective effectiveness of an inactivated bovine ephemeral fever virus vaccine

Veterinary Microbiology

Volumn 173, Issue 1-2, 2014, Pages 1-8

  Aziz Boaron, Orly ^a   Gleser, Dan ^a   Yadin, Hagai ^b   Gelman, Boris ^b   Kedmi, Maor ^c   Galon, Nadav ^d   Klement, Eyal ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b KIMRON VETERINARY INSTITUTE   (Israel)

^c Hachaklait Veterinary Services Ltd   (Israel)

^d Israel Veterinary Services   (Israel)

Author keywords

Bovine ephemeral fever; Efficacy; Immunological memory; Inactivated vaccine; Vaccine effectiveness; Vaccine non responsiveness

Indexed keywords

BOVINE EPHEMERAL FEVER VIRUS VACCINE; INACTIVATED VACCINE; MONTANIDE ISA 206VG; NEUTRALIZING ANTIBODY; RNA VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS VACCINE;

ANTIBODY TITER; ARTICLE; BOVINE EPHEMERAL FEVER; BOVINE EPHEMERAL FEVER VIRUS; CONTROLLED STUDY; DAIRY CATTLE; FEMALE; FIELD STUDY; HEIFER; IMMUNOGENICITY; MILK PRODUCTION; MORBIDITY; NONHUMAN; SEROLOGY; VACCINATION; ANIMAL; BLOOD; BOVINAE; CATTLE DISEASES; EPHEMERAL FEVER; EPIDEMIC; EPIDEMIOLOGY; IMMUNIZATION; IMMUNOLOGY; ISRAEL; MALE; VETERINARY; WEIGHT GAIN;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CATTLE; CATTLE DISEASES; DISEASE OUTBREAKS; EPHEMERAL FEVER; EPHEMERAL FEVER VIRUS, BOVINE; FEMALE; IMMUNIZATION SCHEDULE; ISRAEL; MALE; VACCINATION; VACCINES, INACTIVATED; VIRAL VACCINES; WEIGHT GAIN;

EID: 84906790391     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2014.06.021     Document Type: Article

References (27)

1. Abramson J.H. WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol. Perspect. Innovations 2004, 1.
2. Abramson J.H. WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiol. Perspect. Innovations 2011, 8.
3. Aziz-Boaron O., Klausner Z., Hasoksuz M., Shenkar J., Gafni O., Gelman B., David D., Klement E. Circulation of bovine ephemeral fever in the Middle East-strong evidence for transmission by winds and animal transport. Vet. Microbiol. 2012, 158:300-307.
4. Aziz-Boaron O., Leibovitz K., Gelman B., Kedmi M., Klement E. Safety, immunogenicity and duration of immunity elicited by an inactivated bovine ephemeral fever vaccine. PLoS One 2013, 8:e82217.
5. Bai W.Y.J., Zhang Z., Jiang C., Lin X. Studies on a vaccine against ephemeral fever. In bovine ephemeral fever and related rhabdoviruses. ACIAR Proc. 1992, 44:111-114.
6. Clifford H.D., Hayden C.M., Khoo S.K., Zhang G., Le Souef P.N., Richmond P. CD46 measles virus receptor polymorphisms influence receptor protein expression and primary measles vaccine responses in naive Australian children. Clin. Vaccine Immunol.: CVI 2012, 19:704-710.
7. Dar P., Kalaivanan R., Sied N., Mamo B., Kishore S., Suryanarayana V.V., Kondabattula G. Montanide ISA 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle. Vaccine 2013, 3327-3332.
8. Della-Porta A.J., Snowdon W.A. An experimental inactivated virus vaccine against bovine ephemeral fever. 2. Do neutralizing antibodies protect against infection?. Vet. Microbiol. 1979, 4:197-208.
9. Della-Porta A.J., Snowdon W.A. Vaccines against bovine ephemeral fever. Aust. Vet. J. 1977, 53:50-51.
10. Elnekave E., Li Y., Zamir L., Even-Tov B., Hamblin P., Gelman B., Hammond J., Klement E. The field effectiveness of routine and emergency vaccination with an inactivated vaccine against foot and mouth disease. Vaccine 2013, 31:879-885.
11. Inaba Y., Kurogi H., Sato K., Goto Y., Omori T., Matumoto M. Formalin-inactivated, aluminum phosphate gel-adsorbed vaccine of bovine ephemeral fever virus. Arch. Gesamte Virusforsch. 1973, 42:42-53.
12. Meuer S.C., Dumann H., Meyer zum Buschenfelde K.H., Kohler H. Low-dose interleukin-2 induces systemic immune responses against HBsAg in immunodeficient non-responders to hepatitis B vaccination. Lancet 1989, 1:15-18.
13. Nak-Hyung Lee J.-A.L., Seung-Yong Park, Chang-Seon Song, In-Soo Choi, Joong-Bok Lee A review of vaccine development and research for industry animals in Korea. Clin. Exp. Vaccine Res. 2012, 1:18-34.
14. Pastoret P.P. Human and animal vaccine contaminations. Biologicals 2010, 38:332-334.
15. Plotkin S.A. Correlates of protection induced by vaccination. Clin. Vaccine Immunol.: CVI 2010, 17:1055-1065.
16. Sadoff J.C., Wittes J. Correlates, surrogates, and vaccines. J. Infect. Dis. 2007, 196:1279-1281.
17. Samina I., Zakay-Rones Z., Peleg B.A. Homologous and heterologous antibody response of cattle and sheep after vaccination with foot and mouth disease and influenza viruses. Vaccine 1998, 16:551-557.
18. Snowdon W.A. Bovine ephemeral fever: the reaction of cattle to different strains of ephemeral fever virus and the antigenic comparison of two strains of virus. Aust. Vet. J. 1970, 46:258-266.
19. Studer E., Bertoni G., Candrian U. Detection and characterization of pestivirus contaminations in human live viral vaccines. Biologicals 2002, 30:289-296.
20. Theodoridis A., Boshoff S.E.T., Botha M.J. Studies on the development of a vaccine against bovine ephemeral fever. Onderstepoort J. Vet. Res. 1973, 40:77-82.
21. Tzipory S., Spradbrow P.B. Studies on vaccines against bovine-ephemeral fever. Aust. Vet. J. 1973, 49:183-187.
22. Tzipory S., Spradbrow P.B. A cell culture vaccine against bovine ephemeral fever. Aust. Vet. J. 1978, 54:323-328.
23. Vanselow B.A., Abetz I., Trenfield K. A bovine ephemeral fever vaccine incorporating adjuvant Quil A: a comparative study using adjuvants Quil A, aluminium hydroxide gel and dextran sulphate. Vet. Rec. 1985, 117:37-43.
24. Vanselow B.A., Walthall J.C., Abetz I. Field trials of ephemeral fever vaccines. Vet. Microbiol. 1995, 46:117-130.
25. Walker P.J. Bovine ephemeral fever in Australia and the world. Curr. Top. Microbiol. Immunol. 2005, 292:57-80.
26. Wang F.I., Hsu A.M., Huang K.J. Bovine ephemeral fever in Taiwan. J. Vet. Diagn. Invest. 2001, 13:462-467.
27. Welsh R.M., Selin L.K. No one is naive: the significance of heterologous T-cell immunity. Nat. Rev. Immunol. 2002, 2:417-426.